Work

Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy

Year: 2012

Type: article

Source: Gene Therapy

DOI: 10.1038/gt.2012.75

Authors: L Zhang, Z Yu, P Muranski, D C Palmer, N P Restifo, S A Rosenberg, R A Morgan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, National Heart, Lung, and Blood Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: Adoptive Cell Transfer Immunotherapy of Cancer

OpenAlex ID: W1977258469

FWCI: 1.958

Cites: 42

Cited by: 93

Related to: 10